This book investigates the complex interplay between immunosuppression induced by cyclophosphamide and the efficacy of serotherapy in combating rabies infection in a murine model. The research details the specific virological effects observed when cyclophosphamide, a known immunosuppressant, is administered to mice infected with rabies. It then examines how serotherapy, utilizing antibodies to neutralize the virus, performs under these altered immunological conditions, presenting data on the level of protection achieved.

The research presented in this work likely appeals to specialists in virology, immunology, and experimental medicine. Its focus on a specific experimental model and therapeutic intervention suggests a detailed, data-driven approach. The findings would contribute to the understanding of how immunosuppression affects the response to viral diseases and the effectiveness of antibody-based treatments. The publication in a scientific context implies a rigorous peer-review process, lending authority to its conclusions within the research community.